1,25-Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

Ji H. Lee, Sunyoung Park, Soyoung Cheon, Joo H. Lee, Sunghan Kim, Dae Y. Hur, Tae Sung Kim, Suk R. Yoon, Yoolhee Yang, Sa I. Bang, Hyunjeong Park, Hoon T. Lee, Dae Ho Cho

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The active metabolite of vitamin D 3, 1α,25(OH) 2D 3, displays anticancer effects by regulating cell cycle and apoptosis in many cancer cells. However, it has not been determined whether 1α,25(OH) 2D 3 increases the susceptibility of cancer cells to NK cells. Here, we investigated the anticancer effect of 1α,25(OH) 2D 3 in human melanoma cell lines by investigating enhancement of NK susceptibility and elucidating the mediator of NK cytotoxicity. 1α,25(OH) 2D 3-resistant melanoma cells (G-361 and SK-MEL-5) treated with 1α,25(OH) 2D 3 showed higher susceptibility to NK cells with up-regulation of Fas expression. Furthermore, G-361 cells treated with 1α,25(OH) 2D 3 showed significantly increased caspase activity. In addition to Fas up-regulation, expression of heat shock protein 60 (Hsp60) was elevated by 1α,25(OH) 2D 3. Increased expression of Hsp60 by 1α,25(OH) 2D 3 was related to not only up-regulation of Fas expression but also to NK susceptibility of G-361 cells. Taken together, our data suggest that 1α,25(OH) 2D 3 acts as an anticancer agent by increasing expression of Fas on the surface of melanoma cells through Hsp60 induction and strengthens caspase sensitivity to Fas-mediated apoptotic pathway by NK cells. 1α,25(OH) 2D 3 treatment may therefore have a preventive role in melanoma occurrence or potentiate the anticancer effects of NK-cell immune therapy.

Original languageEnglish
Pages (from-to)2937-2946
Number of pages10
JournalEuropean Journal of Immunology
Volume41
Issue number10
DOIs
Publication statusPublished - 2011 Oct 1

Fingerprint

Chaperonin 60
Natural Killer Cells
Gastrin-Secreting Cells
Melanoma
Up-Regulation
Caspases
Cholecalciferol
Cell- and Tissue-Based Therapy
Antineoplastic Agents
Neoplasms
Cell Cycle
Apoptosis
Cell Line
1,25-dihydroxyvitamin D

Keywords

  • 1α,25(OH) D
  • Fas
  • HSP
  • Melanoma
  • NK cells

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

1,25-Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression. / Lee, Ji H.; Park, Sunyoung; Cheon, Soyoung; Lee, Joo H.; Kim, Sunghan; Hur, Dae Y.; Kim, Tae Sung; Yoon, Suk R.; Yang, Yoolhee; Bang, Sa I.; Park, Hyunjeong; Lee, Hoon T.; Cho, Dae Ho.

In: European Journal of Immunology, Vol. 41, No. 10, 01.10.2011, p. 2937-2946.

Research output: Contribution to journalArticle

Lee, JH, Park, S, Cheon, S, Lee, JH, Kim, S, Hur, DY, Kim, TS, Yoon, SR, Yang, Y, Bang, SI, Park, H, Lee, HT & Cho, DH 2011, '1,25-Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression', European Journal of Immunology, vol. 41, no. 10, pp. 2937-2946. https://doi.org/10.1002/eji.201141597
Lee, Ji H. ; Park, Sunyoung ; Cheon, Soyoung ; Lee, Joo H. ; Kim, Sunghan ; Hur, Dae Y. ; Kim, Tae Sung ; Yoon, Suk R. ; Yang, Yoolhee ; Bang, Sa I. ; Park, Hyunjeong ; Lee, Hoon T. ; Cho, Dae Ho. / 1,25-Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression. In: European Journal of Immunology. 2011 ; Vol. 41, No. 10. pp. 2937-2946.
@article{fe25fa69bc6c4c8bbac3f70aa83190af,
title = "1,25-Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression",
abstract = "The active metabolite of vitamin D 3, 1α,25(OH) 2D 3, displays anticancer effects by regulating cell cycle and apoptosis in many cancer cells. However, it has not been determined whether 1α,25(OH) 2D 3 increases the susceptibility of cancer cells to NK cells. Here, we investigated the anticancer effect of 1α,25(OH) 2D 3 in human melanoma cell lines by investigating enhancement of NK susceptibility and elucidating the mediator of NK cytotoxicity. 1α,25(OH) 2D 3-resistant melanoma cells (G-361 and SK-MEL-5) treated with 1α,25(OH) 2D 3 showed higher susceptibility to NK cells with up-regulation of Fas expression. Furthermore, G-361 cells treated with 1α,25(OH) 2D 3 showed significantly increased caspase activity. In addition to Fas up-regulation, expression of heat shock protein 60 (Hsp60) was elevated by 1α,25(OH) 2D 3. Increased expression of Hsp60 by 1α,25(OH) 2D 3 was related to not only up-regulation of Fas expression but also to NK susceptibility of G-361 cells. Taken together, our data suggest that 1α,25(OH) 2D 3 acts as an anticancer agent by increasing expression of Fas on the surface of melanoma cells through Hsp60 induction and strengthens caspase sensitivity to Fas-mediated apoptotic pathway by NK cells. 1α,25(OH) 2D 3 treatment may therefore have a preventive role in melanoma occurrence or potentiate the anticancer effects of NK-cell immune therapy.",
keywords = "1α,25(OH) D, Fas, HSP, Melanoma, NK cells",
author = "Lee, {Ji H.} and Sunyoung Park and Soyoung Cheon and Lee, {Joo H.} and Sunghan Kim and Hur, {Dae Y.} and Kim, {Tae Sung} and Yoon, {Suk R.} and Yoolhee Yang and Bang, {Sa I.} and Hyunjeong Park and Lee, {Hoon T.} and Cho, {Dae Ho}",
year = "2011",
month = "10",
day = "1",
doi = "10.1002/eji.201141597",
language = "English",
volume = "41",
pages = "2937--2946",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "10",

}

TY - JOUR

T1 - 1,25-Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

AU - Lee, Ji H.

AU - Park, Sunyoung

AU - Cheon, Soyoung

AU - Lee, Joo H.

AU - Kim, Sunghan

AU - Hur, Dae Y.

AU - Kim, Tae Sung

AU - Yoon, Suk R.

AU - Yang, Yoolhee

AU - Bang, Sa I.

AU - Park, Hyunjeong

AU - Lee, Hoon T.

AU - Cho, Dae Ho

PY - 2011/10/1

Y1 - 2011/10/1

N2 - The active metabolite of vitamin D 3, 1α,25(OH) 2D 3, displays anticancer effects by regulating cell cycle and apoptosis in many cancer cells. However, it has not been determined whether 1α,25(OH) 2D 3 increases the susceptibility of cancer cells to NK cells. Here, we investigated the anticancer effect of 1α,25(OH) 2D 3 in human melanoma cell lines by investigating enhancement of NK susceptibility and elucidating the mediator of NK cytotoxicity. 1α,25(OH) 2D 3-resistant melanoma cells (G-361 and SK-MEL-5) treated with 1α,25(OH) 2D 3 showed higher susceptibility to NK cells with up-regulation of Fas expression. Furthermore, G-361 cells treated with 1α,25(OH) 2D 3 showed significantly increased caspase activity. In addition to Fas up-regulation, expression of heat shock protein 60 (Hsp60) was elevated by 1α,25(OH) 2D 3. Increased expression of Hsp60 by 1α,25(OH) 2D 3 was related to not only up-regulation of Fas expression but also to NK susceptibility of G-361 cells. Taken together, our data suggest that 1α,25(OH) 2D 3 acts as an anticancer agent by increasing expression of Fas on the surface of melanoma cells through Hsp60 induction and strengthens caspase sensitivity to Fas-mediated apoptotic pathway by NK cells. 1α,25(OH) 2D 3 treatment may therefore have a preventive role in melanoma occurrence or potentiate the anticancer effects of NK-cell immune therapy.

AB - The active metabolite of vitamin D 3, 1α,25(OH) 2D 3, displays anticancer effects by regulating cell cycle and apoptosis in many cancer cells. However, it has not been determined whether 1α,25(OH) 2D 3 increases the susceptibility of cancer cells to NK cells. Here, we investigated the anticancer effect of 1α,25(OH) 2D 3 in human melanoma cell lines by investigating enhancement of NK susceptibility and elucidating the mediator of NK cytotoxicity. 1α,25(OH) 2D 3-resistant melanoma cells (G-361 and SK-MEL-5) treated with 1α,25(OH) 2D 3 showed higher susceptibility to NK cells with up-regulation of Fas expression. Furthermore, G-361 cells treated with 1α,25(OH) 2D 3 showed significantly increased caspase activity. In addition to Fas up-regulation, expression of heat shock protein 60 (Hsp60) was elevated by 1α,25(OH) 2D 3. Increased expression of Hsp60 by 1α,25(OH) 2D 3 was related to not only up-regulation of Fas expression but also to NK susceptibility of G-361 cells. Taken together, our data suggest that 1α,25(OH) 2D 3 acts as an anticancer agent by increasing expression of Fas on the surface of melanoma cells through Hsp60 induction and strengthens caspase sensitivity to Fas-mediated apoptotic pathway by NK cells. 1α,25(OH) 2D 3 treatment may therefore have a preventive role in melanoma occurrence or potentiate the anticancer effects of NK-cell immune therapy.

KW - 1α,25(OH) D

KW - Fas

KW - HSP

KW - Melanoma

KW - NK cells

UR - http://www.scopus.com/inward/record.url?scp=80053139927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053139927&partnerID=8YFLogxK

U2 - 10.1002/eji.201141597

DO - 10.1002/eji.201141597

M3 - Article

C2 - 21792879

AN - SCOPUS:80053139927

VL - 41

SP - 2937

EP - 2946

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 10

ER -